Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low ‐density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report

Journal of Clinical Apheresis, EarlyView.

Source: Journal of Clinical Apheresis - April 11, 2018 Category: Hematology Authors: M. G.Zenti , C.Stefanutti , V.Sanga , A.Altomari , A.Fabris , M.Dauriz , E.Bonora Source Type: research